Cargando…
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain
Two decades of investigations have failed to unequivocally clarify the functions and the molecular nature of imidazoline-2 receptors (I2R). However, there is robust pharmacological evidence for the functional modulation of monoamino oxidase (MAO) and other important enzyme activities by I2 site liga...
Autores principales: | Ferrari, Flora, Fiorentino, Simonetta, Mennuni, Laura, Garofalo, Paolo, Letari, Ornella, Mandelli, Stefano, Giordani, Antonio, Lanza, Marco, Caselli, Gianfranco |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100226/ https://www.ncbi.nlm.nih.gov/pubmed/21647215 http://dx.doi.org/10.2147/JPR.S18353 |
Ejemplares similares
-
Modulation of NMDA receptor activity by CR4056, an imidazoline-2 receptor ligand with analgesic properties
por: Puja, Giulia, et al.
Publicado: (2022) -
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis
por: Comi, Eleonora, et al.
Publicado: (2017) -
Modulation of imidazoline I(2) binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats
por: Lanza, Marco, et al.
Publicado: (2014) -
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats
por: Meregalli, Cristina, et al.
Publicado: (2012) -
Discriminative stimulus effects of the novel imidazoline I(2) receptor ligand CR4056 in rats
por: Qiu, Yanyan, et al.
Publicado: (2014)